Psychiatry · Milford, MA
NPI
1497719132
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
229 East Main St Suit #204
Milford, MA, 01757
Phone (508) 458-9060
Medicare paid, 2024
$143K
2,035 services
Medicare patients, 2024
166
Average age 63
Drug cost, 2024
$1.4M
5,554 prescriptions
Company payments, 2025
$3,374
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Xiangyang Li was code 99214 (office e&m - established), 639 times for 149 patients. In total Xiangyang Li billed 2,035 services in 8 codes, and Medicare paid $143K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 639 | 149 | $90.74 | $58K |
| 90833 Psychotherapy - Nongroup | Office | 61 | 39 | $54.83 | $3,345 |
| 99213 Office E&M - Established | Office | 55 | 23 | $61.47 | $3,381 |
| 99205 Office E&M - New | Office | 19 | 19 | $158.07 | $3,003 |
By year: 2022 $148K for 1,887 services; 2023 $171K for 1,984 services; 2024 $143K for 2,035 services.
Medicare prescription drug claims, 2024
In 2024, the drug Xiangyang Li prescribed most often to Medicare patients was Quetiapine Fumarate, with 349 prescriptions and refills. In total Xiangyang Li wrote 5,554 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 349 | 435 | 43 | $4,269 |
| Spravato Esketamine Hcl | 324 | 324 | 13 | $406K |
| Buspirone Hcl Generic | 262 | 365 | 43 | $5,198 |
| Mirtazapine Generic | 247 | 319 | 41 | $3,137 |
| Gabapentin Generic | 202 | 232 | 25 | $1,678 |
| Alprazolam Generic | 199 | 219 | 28 | $1,695 |
| Clonazepam Generic | 194 | 195 | 23 | $1,352 |
| Lorazepam Generic | 192 | 200 | 26 | $1,420 |
| Lamotrigine Generic | 177 | 272 | 26 | $1,743 |
| Trazodone Hcl Generic | 162 | 259 | 34 | $1,772 |
| Duloxetine Hcl Generic | 159 | 256 | 31 | $2,794 |
| Sertraline Hcl Generic | 157 | 224 | 25 | $1,297 |
| Bupropion Hcl Sr Bupropion Hcl | 128 | 186 | 25 | $2,014 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 118 | 158 | 16 | $1,330 |
| Bupropion Xl Bupropion Hcl | 115 | 185 | 22 | $2,117 |
Brand drugs: 782 claims; generic drugs: 4,772 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Xiangyang Li $3,374 ($3,374 in general payments such as food, travel and fees) from 18 companies. The largest payer was Vanda Pharmaceuticals Inc. with $498.
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. VNDA | 32 | $498 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 29 | $472 |
| Alkermes, Inc. ALKS | 23 | $421 |
| Axsome Therapeutics, Inc. AXSM | 16 | $331 |
| Janssen Pharmaceuticals, Inc JNJ | 13 | $284 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 12 | $246 |
| Lundbeck LLC | 10 | $230 |
| Neurocrine BioSciences, Inc. NBIX | 12 | $195 |
| Abbvie Inc. ABBV | 12 | $186 |
| Teva Pharmaceuticals USA, Inc. TEVA | 8 | $171 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.